Galapagos NV
GLPG
#4576
Rank
A$3.24 B
Marketcap
A$49.30
Share price
0.00%
Change (1 day)
25.19%
Change (1 year)

Galapagos NV (GLPG) - P/B ratio

P/B ratio as of January 2026 : 0.7598

According to Galapagos NV's latest financial reports the company has a price-to-book ratio of 6.81515.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Galapagos NV - P/B ratio (from 2008 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-310.757927.01%
2024-12-310.5968-31.15%
2023-12-310.8668-19.62%
2022-12-311.08-11.64%
2021-12-311.22-38.1%
2020-12-311.97-52.99%
2019-12-314.1916.07%
2018-12-313.61-8.65%
2017-12-313.965.92%
2016-12-313.73-39.55%
2015-12-316.18171.33%
2014-12-312.28-16.16%
2013-12-312.72-24.72%
2012-12-313.6155.46%
2011-12-312.327.73%
2010-12-312.1531.8%
2009-12-311.6387.45%
2008-12-310.8717

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
AstraZeneca
AZN
6.31 731.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
6.37 738.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.34 75.89%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
-150-19,794.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
2.00 163.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
4.23 456.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
5.19 582.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
4.81 532.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
5.25 591.56%๐Ÿ‡บ๐Ÿ‡ธ USA